The 2026 Neuropathic Pain Market: Decoupling from Opioids through Targeted Neuro-Modulation
As of 2026, the clinical approach to chronic nerve damage has undergone a fundamental structural re-alignment. The Neuropathic Pain Market is no longer dominated by broad-spectrum systemic analgesics; instead, it has transitioned into a precision-driven sector focusing on peripheral selectivity and localized intervention. This shift is primarily fueled by the global mandate to reduce...
ไลค์
4
2 ความคิดเห็น 0 แชร์ 435 ยอดวิว 0 รีวิว